In Memory of James L. Sorensen, PhD |
|
The CTN Dissemination Library is sad to report that James L. Sorensen, PhD, respected and beloved member of the CTN Western States Node, has passed away. We received the following information sent to CPDD members; it includes details on how you can support Dr. Sorensen's family in this difficult time through donations to various organizations he cared about:
With a heavy heart and deep sadness, we are informing CPDD members about the recent passing of our esteemed colleague, Dr. James L. Sorensen. For those of you who knew Jim, he was an incredible man with a warm heart and gentle spirit. He made a profound impact on the field of addiction and a major contribution to our understanding of treatment for individuals with HIV/AIDS and substance use disorders. In recent years, his research focused on linking research and practice in the addictions and studying ethical issues faced by staff when providing treatment for substance use disorders. He mentored many trainees over the past 45 years, who can attest to his generous and influential mentorship. Notably, Jim made significant efforts to remove barriers facing ethnic minorities and women in clinical and health-services research and to encourage the development of researchers from underrepresented populations. Jim was regarded fondly by those who worked with him and especially the San Francisco Bay area addiction treatment community.
Jim was an active member of the College on Problems of Drug Dependence (CPDD) and served in many roles including Media Relations Committee, Nominating Committee, Task Force on Education, Board of Directors, Under-Represented Populations Committee (Chair), and Membership Committee. He was also a founding member and Fellow of the American Psychological Association, Division 50, Society of Addiction Psychology, and a founding Consulting Editor of Psychology of Addictive Behaviors.
Jim obtained his PhD in Clinical Psychology at the University of Rochester, NY in 1975. He then spent three years at Bowling Green University, OH as an Assistant Professor before taking a postdoctoral fellowship at the University of California, San Francisco (UCSF). He built his career at UCSF and recently retired as Professor Emeritus, continuing to work part-time.
An experienced investigator, he published over 250 articles, chapters, and books. A seasoned leader, Dr. Sorensen was the Chief of Substance Abuse Services at San Francisco General Hospital (SFGH) from 1982 through 1995. He led numerous NIH R01 research grants, was Director of the NIDA-funded San Francisco Treatment Research Unit (1989-1994) along with numerous other NIH and non-governmentally supported research and training programs including the California-Arizona Node and later co-lead the Western States Node of the National Drug Abuse Treatment Clinical Trials Network.
Dr. Sorensen was a member of the Institute of Medicine Committee on Community-Based Drug Treatment, which produced the report that led to development of the Clinical Trials Network, and he made the linking of research and practice his major area of focus. Dr. Sorensen was highly dedicated to training future clinicians and researchers, and a valued faculty mentor at UCSF and SFGH. He co-led and directed the NIDA-funded T32 Postdoctoral Training Program in Drug Abuse Treatment and Services Research for many years, was a co-director of the CAPS Visiting Professor R25 program and led the Public Service and Minority Cluster of the Clinical Psychology Training Program at SFGH. He was program director and co-director for the Learning for Early Careers in Addiction & Diversity (LEAD) Program at UCSF.
In 2012 Jim received the George Sarlo Prize for Excellence in Teaching, the highest teaching honor in the UCSF Department of Psychiatry, and in 2013 he received the annual Mentorship Award of the College on Problems of Drug Dependence. In 2015 Jim was honored with the Miracles Tribute award for lifetime achievement and outstanding service in the treatment of addiction and co-occurring disorders, from Constellation Behavioral Health's Alta Mira Recovery Programs in Sausalito, California.
Jim was also a Fulbright Scholar in Calgary, Alberta, Canada during the 2018-2019 academic year where he focused on the ethical issues that confront addiction treatment staff. In the last decade, he taught a course on ethical and legal issues to students at UC Berkeley extension enrolled in an addiction counseling certification program. These remarkable accomplishments represent the areas in which Jim was passionate and reflect his deep commitment to the field of substance use treatment.
We will share any opportunities to celebrate and honor Dr. Sorensen's life and legacy as we hear about them. Jim’s wife, Laurel Koepernik, has requested: In lieu of flowers, tax-deductible donations can be made to UCSF Foundation in honor of Dr. James L. Sorensen (please note in the online form that the contribution is in memory of Dr. Sorensen). These donations will contribute to the support of UCSF-based, and NIDA-funded training programs that were important to Jim.
Alternatively, donations to 100 Friends are welcome! Under Jim’s signature on every email, he stated: "If you have a chance, check out my favorite charity, 100 Friends. The foundation was started by a former research coordinator who worked with us, and I'm convinced it's doing a lot of good."
Legacy memorials in Jim’s name are also being planned with Jim’s professional organizations. Future announcements will be shared through APA Division 50, CPDD, and NIDA.
Sincerest condolences from the CTN Dissemination Library to all those who knew and loved Dr. Sorensen. |
CTN Trial Progress
Randomizations for Active Studies as of the June 19 Trial Progress Report.
CTN-0080 - Enrolled 140
CTN-0096 - Enrolled 11
CTN-0098 - Enrolled 149
CTN-0099 - Enrolled 1552
CTN-0099-A-1 - Enrolled 100
CTN-0100
Discontinuation - Enrolled 160
Retention - Enrolled 817
CTN-0101 - Enrolled 202
CTN-0107 - Enrolled 148
CTN-0108 - Enrolled 83
CTN-0109 - Enrolled 6
CTN-0110 - Enrolled 4
CTN-0116 - Enrolled 85
|
· · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · ·
· · · · · · · · · · · · · · · · · · · · · · ·
Call for Abstracts Open for the Science of D&I Conference
AcademyHealth and the National Institutes of Health are once again convening the growing D&I science community for the 16th Annual Conference on the Science of Dissemination and Implementation in Health. The 16th Annual Conference theme is "Raising Expectations for D&I Science: Challenges and Opportunities."The abstract solicitation and conference structure have been designed to focus our thinking and discussion on the highest priorities for dissemination and implementation science now and in the future to help optimize health and health care in the U.S. and globally. Does this sound like your work? Submit your abstract today!
Abstracts due by July 18, 2023, at 5pm ET!
· · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · ·
· · · · · · · · · · · · · · · · · · · · · · ·
NIDA Racial Equity Initiative: Notices of Funding Opportunities (NOFOs)
These NOFOs are focused on research to advance equity for racial and/or ethnic minority populations in the United States. The NOFOs call for innovative, solution-oriented, community-engaged research from research teams with a commitment to broad dissemination of findings. Applications are expected to incorporate diverse perspectives. Please note that some NOFOs are open to all institutions, and some are limited to applications from Minority Serving Institutions (see Section III of the respective NOFOs for eligibility criteria).
A recording of the TA webinar that was held on September 26, 2022, during which NIDA staff provided an overview of the NOFOs and responded to questions is now available. Please note that the RFA-DA-23-025: NIDA REI: Coordination Center to Support Racial Equity and Substance Use Disparities Research (U24 Clinical Trial Not Allowed) NOFO has expired.
The NOFOs and webinar information can be found on the NIDA Racial Equity Initiative Funding Priority website. The NOFOs are also listed in the NIH Guide.
Please reach out to the NIDA staff listed on the NOFOs with questions!
HIV and Substance Use. Multiple receipt dates. Next due date of November 14, 2023.
RFA-DA-23-062: NIDA REI: Reaching Equity at the Intersection of HIV and Substance Use: Novel Approaches to Address HIV Related Health Disparities in Underserved Racial/Ethnic Populations (R34 Clinical Trial Optional)
RFA-DA-23-061: NIDA REI: Reaching Equity at the Intersection of HIV and Substance Use: Novel Approaches to Address HIV Related Health Disparities in Underserved Racial/Ethnic Populations (R01 Clinical Trial Optional)
Community Engaged R01 Projects. Multiple receipt dates. Next due date of November 14, 2023.
RFA-DA-23-013: NIDA REI: Addressing Racial Equity in Substance Use and Addiction Outcomes Through Community-Engaged Research (R01 Clinical Trial Optional)
RFA-DA-23-032: NIDA REI: Addressing Racial Equity in Substance Use and Addiction Outcomes Through Community-Engaged Research at Minority Serving Institutions (R01 Clinical Trial Optional) *Limited eligibility, see Section III of NOFO
Racial Equity Visionary Award Program. Multiple receipt dates. Next due date of November 14, 2023.
RFA-DA-23-026: NIDA REI: Racial Equity Visionary Award Program for Research on Substance Use and Racial Equity (DP1 Clinical Trial Optional)
RFA-DA-23-031: NIDA REI: Racial Equity Visionary Award Program for Research at Minority Serving Institutions on Substance Use and Racial Equity (DP1 Clinical Trial Optional) *Limited eligibility, see Section III of NOFO
Neurocognitive Mechanisms. Multiple receipt dates. Next due date of November 14, 2023.
RFA-DA-23-028: NIDA REI: Research on Neurocognitive Mechanisms Underlying the Impact of Structural Racism on the Substance Use Trajectory (R61/R33 Clinical Trial Optional)
RFA-DA-23-029: NIDA REI: Research at Minority Serving Institutions on Neurocognitive Mechanisms Underlying the Impact of Structural Racism on the Substance Use Trajectory (R61/R33 Clinical Trial Optional) *Limited eligibility, see Section III of NOFO
· · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · ·
· · · · · · · · · · · · · · · · · · · · · · ·
NIDA HIV Seminar Series: Ending the HIV Epidemic in the US (July 26, 1pm PT)
Join the NIDA HIV Research Program in welcoming Bohdan Nosyk, PhD, Associate Professor and St. Paul’s Hospital CANFAR Chair in HIV/AIDS Research at Simon Fraser University, for the next installment of the NIDA HIV Seminar Series titled “Ending the HIV/AIDS Epidemic in the US: How Do We Intervene to Meet Our Ambitious Goals?”
Bohdan Nosyk is an Associate Professor and St. Paul’s Hospital CANFAR Chair in HIV/AIDS Research at the Faculty of Health Sciences, and leads the Health Economic Research Unit at the Center for Health Evaluation & Outcome Sciences. Dr. Nosyk’s research seeks to inform complex policy decisions surrounding the prevention and management of HIV/AIDS and substance use disorders. He has led population-level evaluations in these disease areas in China, in the state of California and across urban centers in the US, and locally in British Columbia. He combines simulation modeling methods and cost-effectiveness analyses with econometric and biostatistical analyses of health administrative data to address these issues. Dr. Nosyk’s teaching interests are in the areas of health economic evaluation and health services research.
Register here!
|
Youth SIG Webinar: Recording Available!
Did you miss May's webinar from the CTN Youth Special Interest Group?
This session, Getting Evidence-Based Treatments to Youth and Families Who are Involved in the Juvenile Legal System, featured Dr. Ashli Sheidow’s talking about her services research, which examines methods and tools for getting substance use interventions to youth with juvenile legal system involvement. She will present lessons learned, with a focus on a task-shifting study with juvenile probation officers delivering contingency management treatment to youth and their parents/caregivers. The presentation included insights into training and support for different providers, as well as lessons learned about services research design and methods.
Find the recording here! |
· · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · ·
· · · · · · · · · · · · · · · · · · · · · · ·
New in the CTN Dissemination Library
The 2023 CTN Directory is here! Trying to find a colleague's email address? Look no further! The latest CTN Directory is now available on the CTN Library website!
Psychometric Performance of a Substance Use Symptom Checklist to Help Clinicians Assess Substance Use Disorder in Primary Care. Matson TE, et al. JAMA Network Open 2023;6(5):e2316283. This is the primary outcomes paper for CTN-0113!
National Institute on Drug Abuse Clinical Trials Network Meeting Report: Advancing Emergency Department Initiation of Buprenorphine for Opioid Use Disorder. Cowan E, et al. Annals of Emergency Medicine 2023 (in press).
Patient Engagement in a Multimodal Digital Phenotyping Study of Opioid Use Disorder. Campbell CI, et al. Journal of Medical Internet Research 2023;e45556. This is the primary outcomes paper for CTN-0084-A-2!
· · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · ·
· · · · · · · · · · · · · · · · · · · · · · ·
New from the ATTC
Flipping the Classroom to Improve Intensive Technical Assistance Efforts by Bryan Hartzler, PhD, Northwest ATTC Director. ATTC/NIATx Service Improvement Blog. How can asynchronous learning resources augment intensive technical assistance? By enabling one to "flip the classroom," an educational philosophy that communal learning is less effective via passive instructions methods (didactic, lecture, persuasion, etc.) than active ones involving higher-order, applied tasks (like case formulations or skills training with behavioral rehearsal).
Celebrate Pride Month with These Important Tools from the National SOGIE Center & Partners by Angela Weeks, Director, National SOGIE Center. ATTC Messenger, June 2023.
|
Upcoming Events
International Cannabinoid Research Society Symposium
June 24-29, 2023, Toronto Canada
Research Society on Alcoholism (RSA)
June 24-28, 2023, Bellevue, WA
International Conference on Opioids (ICO)
July 15-16, 2023, Stockholm, Sweden
Find more upcoming events at the NIDA website or on Addiction's Meetings & Conferences page.
|
|